Maharajah's College of Pharmacy Vizianagaram B Pharma is offered as 4 Years Full Time program, with total intake of 60 seats. The minimum eligibility criteria for B Pharma is 10+2 with 50% + EAMCET. The total fees for Maharajah's College of Pharmacy Vizianagaram B Pharma in 2025 is ₹ 2.54 Lakhs for the complete course duration, which includes total tuition fees of ₹ 2.54 Lakhs.
Maharajah's College of Pharmacy Vizianagaram offers a total of 60 seats for B Pharma . Admissions are offered based on AP-EAPCET.
Maharajah's College of Pharmacy Vizianagaram AP-EAPCET Cutoff 2023 rank is 127318 for the BCB category. Further, the cutoff rank is 107628 for BCD category, Earlier, the AP-EAPCET cutoff rank 2022 was 133718 for the General category.
| Fees (2025 - 2026) | Year 1 (in INR) | Year 2 (in INR) | Year 3 (in INR) | Year 4 (in INR) |
|---|---|---|---|---|
| Tuition Fees | ₹63600 | ₹63600 | ₹63600 | ₹63600 |
| Yearly Fees | ₹63600 | ₹63600 | ₹63600 | ₹63600 |
* Fees is refundable
The minimum eligibility for admission to B Pharma at Maharajah's College of Pharmacy Vizianagaram is 10+2 with 50% + EAMCET. Candidates are allotted seats based on AP-EAPCET.
Maharajah's College of Pharmacy Vizianagaram B Pharma Cutoff 2025 has not been released yet. You can check the previous year AP-EAPCET cutoff rank for B Pharma admissions in the section below.
| Categories (2023) | Round 4 |
|---|---|
| BCB | 127318 |
| BCD | 107628 |
| Categories | Round 1 |
|---|---|
| General | 133718 |
| SC | 133718 |
| ST | 133718 |
| BCA | 133718 |
| BCB | 133718 |
| BCC | 133718 |
| BCD | 133718 |
| BCE | 133718 |
Also Check:
| Course Highlights | Details |
|---|---|
| duration | 4 Years (Full Time) |
| course level | UG (Degree) |
| mode of study | On Campus |
| total fees | ₹ 2.54 Lakhs |
| eligibility | 10+2 with 50% + EAMCET |
| Fee Type | Total Amount (INR) |
|---|---|
| tuition fee | ₹2.54 Lakhs |
| total fee | ₹2.54 Lakhs |

Search from 20K+ Courses and 35+ Streams


Do you think the data is wrong ? Report Here


.jpeg?h=78&w=78&mode=stretch)












Comments